CGEM CULLINAN THERAPEUTICS
Health Care · Russell 2000
Next earnings: Sat 14 Nov 2026 · after market close
What 15 analyst firms say about CULLINAN THERAPEUTICS: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
13 rated views · 15 analyst/firm records · 15 firms
Radar score
- Russell 2000 · Top Picks · 6MStrong · #7 in the index93
- Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8061
Recent analyst activity · last 90 days
Our tracked history has 17 reports on CGEM from 10 analyst firms in the last 90 days (15 firms in the past year).
Comparing each firm's latest target with its previous one: 2 raised their price target, 2 left it unchanged and 3 have their first observed target in the past year.
No firm's latest available rating differs from its previous one.
Latest observed target change: BTIG Research raised its target from $40.00 (set 19 Oct 2026) to $41.00 on 28 Oct 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| BTIG | Julian Harrison | Buy | 28 Oct 2026 | 41.00 USD |
| Citigroup | Samantha Semenkow | Buy | 17 Feb 2026 | 33.00 USD |
| Clear Street LLC | Kaveri Pohlman | Buy | 13 Aug 2026 | 47.00 USD |
| Guggenheim | Bradley P Canino | Buy | 14 Sep 2026 | 35.00 USD |
| H.C. Wainwright | Robert Burns | Buy | 2 Oct 2026 | 35.00 USD |
| Jonestrading | Soumit Roy | Buy | 10 Jun 2026 | 36.00 USD |
| Leerink Partners | Andrew Berens | Buy | 13 Aug 2026 | 39.00 USD |
| Morgan Stanley | Jeffrey Hung | Buy | 8 Jan 2026 | 30.00 USD |
| New Street Research | Unnamed analyst | — | 20 Nov 2025 | 26.00 USD |
| TD Cowen | Philip M Nadeau | Buy | 24 Aug 2026 | — |
| UBS | David Dai | Buy | 14 Aug 2026 | 27.00 USD |
| Wedbush | Robert Driscoll | Buy | 15 Sep 2026 | 42.00 USD |
| Weiss Ratings | Unnamed analyst | — | 2 Oct 2026 | — |
| William Blair | Matt Phipps | Buy | 14 Sep 2026 | — |
| Data feed RESEARCH | Research Team | Hold | 19 Feb 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 06:11 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.